Literature DB >> 14194222

DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.

P E FELDMAN, B D FRIERSON.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE TOXICOLOGY; CORNEAL OPACITY; MENSTRUATION DISORDERS; PIGMENTATION DISORDERS; SCHIZOPHRENIA; SKIN MANIFESTATIONS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14194222     DOI： 10.1176/ajp.121.2.187

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT.

Authors:  L W MASSEY
Journal:  Can Med Assoc J       Date:  1965-01-23       Impact factor: 8.262

Review 2.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

3.  Optic atrophy during chlorpromazine therapy.

Authors:  S M Rab; M N Alam; M D Sadequzzaman
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

4.  Ocular melanosis with special reference to chlorpromazine.

Authors:  M E Cameron
Journal:  Br J Ophthalmol       Date:  1967-05       Impact factor: 4.638

5.  Eye and skin changes in psychiatric patients treated with chlorpromazine.

Authors:  M B Mathalone
Journal:  Br J Ophthalmol       Date:  1967-02       Impact factor: 4.638
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.